Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (81-90 of 372) with videos related to

Pageof 38
Sort By:
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
The American Journal of Cardiology|July 13, 2004
Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failureKenneth Dickstein, Hanka J De Voogd, Milutin P Miric, et al.
European Heart Journal|August 8, 2006
Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery diseaseLinn M A Kennedy, Kenneth Dickstein, Stefan D Anker, et al.
European Heart Journal|June 9, 2009
Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary interventionStein Ørn, Cord Manhenke, Ole Jacob Greve, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
European Heart Journal|March 21, 2009
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarctionStein Ørn, Cord Manhenke, Thor Ueland, et al.
Irish Journal of Medical Science|February 7, 2020
Correction to: CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysisDeepti Ranganathan, Zain Sharif, Theodore Murphy, et al.
Irish Journal of Medical Science|January 26, 2020
CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysisDeepti Ranganathan, Zain Sharif, Theodore Murphy, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|April 22, 2022
Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish PopulationDuygu Koçyiğit, Nedim Umutay Sarıgül, Timuçin Altın, et al.
European Journal of Heart Failure|July 21, 2011
The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgradesNigussie Bogale, Klaus Witte, Silvia Priori, et al.
Pageof 38

Showing results (81-90 of 372) with videos related to

Sort By:
Pageof 38
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
The American Journal of Cardiology|July 13, 2004
Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failureKenneth Dickstein, Hanka J De Voogd, Milutin P Miric, et al.
European Heart Journal|August 8, 2006
Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery diseaseLinn M A Kennedy, Kenneth Dickstein, Stefan D Anker, et al.
European Heart Journal|June 9, 2009
Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary interventionStein Ørn, Cord Manhenke, Ole Jacob Greve, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
European Heart Journal|March 21, 2009
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarctionStein Ørn, Cord Manhenke, Thor Ueland, et al.
Irish Journal of Medical Science|February 7, 2020
Correction to: CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysisDeepti Ranganathan, Zain Sharif, Theodore Murphy, et al.
Irish Journal of Medical Science|January 26, 2020
CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysisDeepti Ranganathan, Zain Sharif, Theodore Murphy, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|April 22, 2022
Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish PopulationDuygu Koçyiğit, Nedim Umutay Sarıgül, Timuçin Altın, et al.
European Journal of Heart Failure|July 21, 2011
The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgradesNigussie Bogale, Klaus Witte, Silvia Priori, et al.
Pageof 38